Apple Podcast：BMJ Podcasts Podcast 節目

頻道・共 22 個節目

醫學

醫學

每月更新
醫學

醫學

每月更新
醫學

醫學

每月更新
醫學

醫學

每月更新兩次
醫學

醫學

隔月更新
醫學

醫學

每月更新
醫學

醫學

4月22日更新

3 天前

Upward tingling, racing glaucoma and the toppling tower of frailty - Editors' Highlights December 2024

Neuromuscular junction disorders can present in a variety of challenging ways, with the potential to mislead neurologists. Journal editors Prof. Philip Smith and Dr. Geraint Fuller begin with this subject as they talk through the latest issue Practical Neurology, for December 2024. The conversation moves to neck flexion and brain zaps, reflects on the undiminished importance of "general" neurology, and also touches on maternal epilepsy risks, frailty's impact on stroke patients, timely recognition of glaucoma, and sustainable practices for green physicians. To finish, there's the now-traditional recital of eponymous syndromes. Read the issue: https://pn.bmj.com/content/24/6 Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production by Letícia Amorim and Brian O'Toole. Editing by Brian O'Toole. Thank you for listening.

3 天前

・

49 分鐘
2 天前

Aspirin: latest evidence and developments

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Mark R Nelson from Tasmania, Australia. They discuss the history of aspirin's medicinal uses, current indications and where it might be useful in the future. If you enjoy the show, please leave us a podcast review wherever you get your podcast - it's very helpful to us! Link to published paper: https://heart.bmj.com/content/110/17/1069.long

2 天前

・

15 分鐘
6 天前

Cancer and Exercise - Let’s beat it together. EP #563

In this episode Dr Kyle Winik is joined by Dr Lervasen Pillay, a Sport and Exercise Physician who has a keen interest in Exercise and Cancer. Through the episode they discuss an approach to a patient battling cancer and try to give an approach to change the narrative that exercise can be used as a tool in cancer management.

6 天前

・

23 分鐘
1 天前

Panic disorder

Panic disorder is common. The prevalence of panic disorder is 2% to 3% in adults and adolescents. And panic disorder can cause distress, substance abuse, and treatment related side effects. So it is important that we get the diagnosis and management of this condition right. To find out more about this problem and what we can do about it, please do listen to his podcast interview with Professor Craig Sawchuk of the Department of Psychiatry and Psychology, Mayo Clinic, Rochester. Craig is the author of our topic on panic disorder on BMJ Best Practice. Competing interests: None

1 天前

・

27 分鐘
3 天前

KEYNOTE-A18 Overall Survival Results: Pembrolizumab and Chemoradiotherapy with Domenica Lorusso

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Domenica Lorusso to discuss KEYNOTE-A18 Overall Survival Results: Pembrolizumab and Chemoradiotherapy. Dr. Domenica Lorusso, MD, PhD, directs the Gynaecological Oncology Unit at Humanitas Hospital, Milan, and holds a Full Professorship in Obstetrics and Gynaecology at Humanitas University, Rozzano, Milan. She has led/participated in approximately 250 phase I-IV clinical trials. Currently overseeing more than 60 studies as Principal Investigator, Dr. Lorusso also chairs the Clinical Trials Committee of the MITO Group. She serves on the Board of Directors of the GCIG and is an active member of ENGOT, where she chairs the Gynecological Cancer Academy. Additionally, she sits on the Board of Directors of the ESGO. With around 300 international oncology publications and contributions to national and international treatment guidelines, her primary objectives are to ensure optimal patient care, foster clinical research, and advance international collaborations and education in the field. Highlights: In a phase 3 trial (ENGOT-cx11/GOG-3047/KEYNOTE-A18), pembrolizumab added to chemoradiotherapy significantly improved progression-free survival and overall survival for patients with locally advanced, high-risk cervical cancer. Patient Group: 1060 patients with FIGO 2014 stage IB2–IVA cervical cancer from 30 countries were randomized to receive pembrolizumab with chemoradiotherapy or placebo with chemoradiotherapy. Overall Survival: At a median follow-up of 29.9 months, the 36-month overall survival rate was 82.6% in the pembrolizumab group versus 74.8% in the placebo group, with a hazard ratio for death of 0.67 (95% CI 0.50–0.90; p=0.0040). Safety Profile: Grade 3 or higher adverse events were reported in 78% of pembrolizumab-treated patients versus 70% in the placebo group, with higher rates of potentially immune-mediated adverse events in the pembrolizumab group (39% vs. 17%). Conclusion: These findings confirm pembrolizumab plus chemoradiotherapy as an effective and potentially new standard of care for locally advanced cervical cancer.

3 天前

・

32 分鐘
11月5日

Management of bicuspid aortic disease in the TAVI era

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by cardiac surgeon Professor Marjan Jahangiri from St George's Hospital, London. They discuss how to manage this condition and how and why TAVI might be used. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful. Link to published paper: https://heart.bmj.com/content/110/22/1291

11月5日

・

16 分鐘
10月11日

Sole Revolution: The Future of Running Shoes and Orthotics with Sports Podiatrist Damir Metljak. EP#561

New-generation running shoes are being developed with the aim of enhancing an athlete's stride length and propulsion force. But what do podiatrists think about these innovative "super shoes"? In this podcast, Dr. Daniel Bastock explores this concept with Damir Metljak, a sports podiatrist based in Adelaide, South Australia. They discuss the biomechanical implications of these shoes, the potential for increased injury risk, and how to design the ideal orthotic to complement the unique characteristics of this footwear.

10月11日

・

28 分鐘
10月10日

Neurotoxicology's top offenders

"Could this presenting syndrome be caused by a neurotoxin?" Oftentimes neurologists will pass over toxins when diagnosing. Yet disease caused by neurotoxins is widespread, with many having quite typical syndromes. In the studio to discuss this is the first author of the October 2024 Editors' Choice paper, Dr. Frederick Vonberg¹. He draws attention to some hobbies and occupations to watch out for, the global prevalence of lead poisoning, presentations of botulism, and the origin of the infamous Mad Hatter syndrome. Read the paper: Neurotoxicology: a clinical systems-based review 1. National Hospital for Neurology and Neurosurgery, Queen Square, London, UK Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest episodes. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. This episode was hosted by PN's podcast editor Dr. Amy Ross Russell. Production by Letícia Amorim, Brian O'Toole, and Amy Ross Russell. Editing by Brian O'Toole.

10月10日

・

37 分鐘
2023/08/07

Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Amrie Grammer and Dr. Peter Lipsky from AMPEL BioSolutions. Together they describe the molecular endotypes of Type 1 and Type 2 Systemic Lupus Erythematosus. This episode uncovers the distinct molecular profiles of these SLE types and paves the way for personalized treatment approaches based on these classifications. Link to published paper: https://lupus.bmj.com/content/10/1/e000861

2023/08/07

・

20 分鐘
11月4日

Uterine fibroids

Uterine fibroids are common. They represent the most common solid tumours of the female pelvis and are a leading indication for hysterectomy. And complications are frequent also - from bleeding to obstetric complications. So what can we do to ensure that we get the diagnosis and management of this condition right? To answer this and other important questions, please do have a listen to this podcast interview with Professor Ayman Al-Hendy, Tenured Professor at the Department of Obstetrics and Gynecology, University of Chicago. Competing interests: AAH has served on the external advisory boards of Bayer, AbbVie, Myovant, Pfizer, ObsEva and Allergan, and has received research funding from the National Institutes of Health.

11月4日

・

23 分鐘

With over 20 shows BMJ Podcasts is the essential podcast network for healthcare professionals around the globe.